IRD — Opus Genetics Share News
0.000.00%
Last trade - 00:00- $317.81m
- $265.20m
- $14.20m
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data
Opus Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Opus Genetics - May Offer And Sell Up To $300 Million Of Securities - SEC Filing
Opus Genetics Inc expected to post a loss of 16 cents a share - Earnings Preview
Opus Genetics Q2 revenue falls and misses estimates
Brief: Opus Genetics Inc Q2 Revenue USD 755 Thousand Vs. IBES Estimate USD 2.47 Million
Brief: Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule
Brief: Opus Genetics Inc Announced Strategic Financing Agreement With Oberland Capital Management Llc
Brief: Opus Genetics Announces FDA Acceptance Of Supplemental New Drug Application For Phentolamine Ophthalmic Solution 0.75% For The Treatment Of Presbyopia
U.S. STOCKS ON THE MOVE-Moderna, Mohawk,
U.S. STOCKS ON THE MOVE-Moderna, Mohawk
U.S. STOCKS ON THE MOVE-Opus Genetics, MetaVia, Enbridge
Opus Genetics gains after raising $25 million for vision therapy programs
Brief: Opus Genetics Announces $25 Million Private Placement
U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer
U.S. STOCKS ON THE MOVE-Applied Materials, CDW, Dell